Latest Personalized medicine Stories
Investment will support scale of global services, development of independent diagnostic tests, and deployment of future companion diagnostic products SAN DIEGO, July 30, 2014 /PRNewswire/
SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops
Bio-ID Diagnostics Inc., the parent company of MultiGEN Diagnostics Inc., has been awarded a US patent for broad based QC/QA applications in clinical diagnostic testing.
GIA announces the release of a comprehensive global report on Molecular Diagnostics markets.
MADISON, Wis., July 24, 2014 /PRNewswire/ -- Restore Health, a leading personalized medicine company that provides specialty and compounded pharmaceuticals, announced that it is now offering
Transparency Market Research published a new report "Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its report store.
OmniSeq Target(TM) testing to guide treatment decisions for patients with lung cancer and other solid tumors BUFFALO, N.Y., July 18, 2014 /PRNewswire-USNewswire/ -- The New York State
Targeted therapy for pancreatic cancer is based on personalized medicine approach Somerville, Massachusetts (PRWEB) July 15, 2014 ANDARIX Pharmaceuticals,
This collaboration complements world-class cancer care with sophisticated scientific research focused on providing targeted therapies DANVILLE, Pa.